Brief: Biohit Concludes Clinical Trials With Acetium
09/08/2019 13:50
Aug 9 (Reuters) - Biohit Oyj BIOBV.HE :
* REG-TWO CLINICAL TRIALS WITH ACETIUM® CAPSULE FOR
PREVENTION OF
MIGRAINE-TYPE HEADACHE HAVE BEEN CONCLUDED
* ALTHOUGH STUDY RESULTS WERE NOT POSITIVE FOR WHOLE COHORT,
SUBGROUP ANALYSES DISCLOSED MIGRAINE PATIENTS WHO BENEFIT FROM
ACETIUM®-CAPSULE.
* IN WHOLE SERIES, ACETIUM® FAILED TO SHOW AN EFFICACY
STATISTICALLY SUPERIOR TO PLACEBO.
* ORIGINALLY PLANNED COHORT SIZE WAS NOT COMPLETELY REACHED.
* MONTHLY HEADACHE DAYS IN THIS SUBGROUP WERE REDUCED BY
MORE THAN
50 %, AND EVEN MORE PATIENTS WERE FOUND WITH A REDUCTION OF UP
TO 25 % OF THEIR MONTHLY MIGRAINE DAYS
Source text for Eikon: ID:nGNE6yQcsw
Further company coverage: BIOBV.HE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))